UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000036970
Receipt number R000041954
Scientific Title Biomarker analysis: Phase II study of nivolumab + abemaciclib + endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer (NEWFLAME) WJOG11418B-TR
Date of disclosure of the study information 2019/06/05
Last modified on 2023/01/10 09:53:13

No. Disposal Last modified on Item of update
1 Insert 2019/06/05 10:40:02
2 Update 2019/09/13 16:33:23 Recruitment status
Date of IRB
Last follow-up date
3 Update 2022/03/01 13:37:03 Recruitment status
4 Update 2023/01/10 09:53:13 Recruitment status